Granules India Q2 FY24 PAT drops 30% at Rs. 102 Cr

Sales in the US region grew well, partially offset by the decline in the LATAM and European regions

Vaishali Pharma posts Q2 FY24 PAT at Rs. 1.70 Cr

he company posted total income during Q2 FY24 at Rs. 12.86 crore

Marksans Pharma posts Q2 FY24 consolidated PAT at Rs. 82.7 Cr

US business grew by +12.8% YoY

Supriya Lifescience reports Q2 FY24 PAT higher 42% at Rs. 23.88 Cr

Gland Pharma posts Q2 FY24 consolidated PAT at Rs. 194.08 Cr

Gland Pharma has reported total income of Rs. 1426.57 crores during the period ended September 30, 2023

Max Healthcare Institute reports Q2 FY24 consolidated PAT at Rs. 276.68 Cr

Max Healthcare Institute has reported total income of Rs. 1408.64 crores during the period ended September 30, 2023

Divis Laboratories posts Q2 FY24 consolidated PAT at Rs. 348 Cr

Divi's Laboratories Limited has reported total income of Rs. 1995 crores during the period ended September 30, 2023

Zydus Wellness consolidated Q2 FY24 PAT drops to Rs. 5.9 Cr

Zydus Wellness has reported total income of Rs. 444 crores during the period ended September 30, 2023

Metropolis Healthcare reports Q2 FY24 consolidated PAT at Rs. 35.45 Cr

Metropolis Healthcare has reported total income of Rs. 309.71 crores during the period ended September 30, 2023

Themis Medicare posts Q2 FY24 PAT at Rs. 11.31 Cr

The company has reported total income of Rs. 107.22 crores during the period ended September 30, 2023